Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
Soy Treatment for High-Risk Women.
Closed to Accrual with Ongoing Follow-up
Defintions of terms and FAQ about clinical trials.
Anna Wu, Ph.D.
Other Trial Staff:
Kristy Watkins, R.N., Wendy Cheng, Coordinator
to see study documents.
You may participate in this study if:
Eligible subjects will be women at high risk for breast cancer, defined as any of the following groups: • Five year Gail risk >1.7% • Known BRCA1/BRCA2 mutation carrier • Family history consistent with hereditary breast cancer • Prior biopsy exhibiting atypical hyperplasia or lobular carcinoma in situ (LCIS) • History of locally confined invasive breast cancer or ductal carcinoma in situ (DCIS) and have completed standard therapy including tamoxifen/aromatase inhibitor or will not be treated with tamoxifen/aromatase inhibitor,
Patient must have signed and dated IRB approved informed consent and HIPAA authorization forms.
You may not participate in this study if:
Metastatic breast cancer
Undergoing treatment (chemotherapy, radiation, or SERMs)
Pregnancy or breast-feeding, or planning to become pregnant within one year prior to study entry
Regular soy consumers (i.e. less than once per week of soy food, soy supplements, or other products)
Not willing to avoid soy foods/supplements during study period
Current users of exogenous hormones or oral contraceptive or planning to use exogenous hormones during the duration of the study
Cannot stop taking aspirin or NSAIDs within a week of breast biopsy
Active participant in other ongoing trials
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.